Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2009

Open Access 01-12-2009 | Research article

Tolerability of inhaled N-chlorotaurine in the pig model

Authors: Ralf Geiger, Benedikt Treml, Anna Pinna, Linn Barnickel, Harald Prossliner, Hannes Reinstadler, Michael Pilch, Maria Hauer, Christoph Walther, Hans-Jörg Steiner, Thomas Giese, Andreas Wemhöner, Sabine Scholl-Bürgi, Waldemar Gottardi, Roland Arnitz, Consolato Sergi, Markus Nagl, Alexander Löckinger

Published in: BMC Pulmonary Medicine | Issue 1/2009

Login to get access

Abstract

Background

N-chlorotaurine, a long-lived oxidant produced by human leukocytes, can be applied in human medicine as an endogenous antiseptic. Its antimicrobial activity can be enhanced by ammonium chloride. This study was designed to evaluate the tolerability of inhaled N-chlorotaurine (NCT) in the pig model.

Methods

Anesthetized pigs inhaled test solutions of 1% (55 mM) NCT (n = 7), 5% NCT (n = 6), or 1% NCT plus 1% ammonium chloride (NH4Cl) (n = 6), and 0.9% saline solution as a control (n = 7), respectively. Applications with 5 ml each were performed hourly within four hours. Lung function, haemodynamics, and pharmacokinetics were monitored. Bronchial lavage samples for captive bubble surfactometry and lung samples for histology and electron microscopy were removed.

Results

Arterial pressure of oxygen (PaO2) decreased significantly over the observation period of 4 hours in all animals. Compared to saline, 1% NCT + 1% NH4Cl led to significantly lower PaO2 values at the endpoint after 4 hours (62 ± 9.6 mmHg vs. 76 ± 9.2 mmHg, p = 0.014) with a corresponding increase in alveolo-arterial difference of oxygen partial pressure (AaDO2) (p = 0.004). Interestingly, AaDO2 was lowest with 1% NCT, even lower than with saline (p = 0.016). The increase of pulmonary artery pressure (PAP) over the observation period was smallest with 1% NCT without difference to controls (p = 0.91), and higher with 5% NCT (p = 0.02), and NCT + NH4Cl (p = 0.05).
Histological and ultrastructural investigations revealed no differences between the test and control groups. The surfactant function remained intact. There was no systemic resorption of NCT detectable, and its local inactivation took place within 30 min. The concentration of NCT tolerated by A549 lung epithelial cells in vitro was similar to that known from other body cells (0.25–0.5 mM).

Conclusion

The endogenous antiseptic NCT was well tolerated at a concentration of 1% upon inhalation in the pig model. Addition of ammonium chloride in high concentration provokes a statistically significant impact on blood oxygenation.
Appendix
Available only for authorised users
Literature
2.
go back to reference Malle E, Waeg G, Schreiber R, Grone EF, Sattler W, Grone HJ: Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem. 2000, 267: 4495-4503.CrossRefPubMed Malle E, Waeg G, Schreiber R, Grone EF, Sattler W, Grone HJ: Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem. 2000, 267: 4495-4503.CrossRefPubMed
3.
go back to reference Grisham MB, Jefferson MM, Melton DF, Thomas EL: Chlorination of endogenous amines by isolated neutrophils. J Biol Chem. 1984, 259: 10404-10413.PubMed Grisham MB, Jefferson MM, Melton DF, Thomas EL: Chlorination of endogenous amines by isolated neutrophils. J Biol Chem. 1984, 259: 10404-10413.PubMed
4.
go back to reference Koprowski M, Marcinkiewicz J: Taurine chloramine – its role in immunity and new perspectives for clinical use. Centr Eur J Immunol. 2002, 27: 69-74. Koprowski M, Marcinkiewicz J: Taurine chloramine – its role in immunity and new perspectives for clinical use. Centr Eur J Immunol. 2002, 27: 69-74.
5.
go back to reference Marcinkiewicz J: Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today. 1997, 18: 577-580.CrossRefPubMed Marcinkiewicz J: Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today. 1997, 18: 577-580.CrossRefPubMed
6.
go back to reference Gottardi W, Nagl M: Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm Pharm Med Chem. 2002, 335: 411-421.CrossRef Gottardi W, Nagl M: Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm Pharm Med Chem. 2002, 335: 411-421.CrossRef
7.
go back to reference Nagl M, Gottardi W: Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med. 1996, 21: 597-605. Nagl M, Gottardi W: Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med. 1996, 21: 597-605.
8.
go back to reference Nagl M, Larcher C, Gottardi W: Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res. 1998, 38: 25-30.CrossRefPubMed Nagl M, Larcher C, Gottardi W: Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res. 1998, 38: 25-30.CrossRefPubMed
9.
go back to reference Nagl M, Hess M, Pfaller K, Hengster P, Gottardi W: Bactericidal activity of micromolar N-chlorotaurine – evidence for its antimicrobial function in the human defence system. Antimicrob Agents Chemother. 2000, 44: 2507-2513.CrossRefPubMedPubMedCentral Nagl M, Hess M, Pfaller K, Hengster P, Gottardi W: Bactericidal activity of micromolar N-chlorotaurine – evidence for its antimicrobial function in the human defence system. Antimicrob Agents Chemother. 2000, 44: 2507-2513.CrossRefPubMedPubMedCentral
10.
go back to reference Nagl M, Lass-Floerl C, Neher A, Gunkel AR, Gottardi W: Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother. 2001, 47: 871-874.CrossRefPubMed Nagl M, Lass-Floerl C, Neher A, Gunkel AR, Gottardi W: Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother. 2001, 47: 871-874.CrossRefPubMed
11.
go back to reference Romanowski EG, Yates KA, Teuchner B, Nagl M, Irschick EU, Gordon YJ: N-Chlorotaurine is an Effective Antiviral Agent against Adenovirus In Vitro and in the Ad5/NZW Rabbit Ocular Model. Invest Ophth Vis Sci. 2006, 47: 2021-2026.CrossRef Romanowski EG, Yates KA, Teuchner B, Nagl M, Irschick EU, Gordon YJ: N-Chlorotaurine is an Effective Antiviral Agent against Adenovirus In Vitro and in the Ad5/NZW Rabbit Ocular Model. Invest Ophth Vis Sci. 2006, 47: 2021-2026.CrossRef
12.
go back to reference Teuchner B, Nagl M, Schidlbauer A, Ishiko H, Dragosits E, Ulmer H, Aoki K, Ohno S, Mizuki N, Gottardi W, et al: Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis – a double-blind randomized phase 2 clinical trial. J Ocular Pharmacol Ther. 2005, 21: 157-165.CrossRef Teuchner B, Nagl M, Schidlbauer A, Ishiko H, Dragosits E, Ulmer H, Aoki K, Ohno S, Mizuki N, Gottardi W, et al: Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis – a double-blind randomized phase 2 clinical trial. J Ocular Pharmacol Ther. 2005, 21: 157-165.CrossRef
13.
go back to reference Nagl M, Nguyen VA, Gottardi W, Ulmer H, Höpfl R: Tolerability and efficacy of N-chlorotaurine compared to chloramine T for treatment of chronic leg ulcers with purulent coating. Br J Dermatol. 2003, 149: 590-597.CrossRefPubMed Nagl M, Nguyen VA, Gottardi W, Ulmer H, Höpfl R: Tolerability and efficacy of N-chlorotaurine compared to chloramine T for treatment of chronic leg ulcers with purulent coating. Br J Dermatol. 2003, 149: 590-597.CrossRefPubMed
14.
go back to reference Neher A, Nagl M, Appenroth E, Gstottner M, Wischatta M, Reisigl F, Schindler M, Ulmer H, Stephan K: Acute Otitis Externa: Efficacy and Tolerability of N-Chlorotaurine, a Novel Endogenous Antiseptic Agent. Laryngoscope. 2004, 114: 850-854.CrossRefPubMed Neher A, Nagl M, Appenroth E, Gstottner M, Wischatta M, Reisigl F, Schindler M, Ulmer H, Stephan K: Acute Otitis Externa: Efficacy and Tolerability of N-Chlorotaurine, a Novel Endogenous Antiseptic Agent. Laryngoscope. 2004, 114: 850-854.CrossRefPubMed
15.
go back to reference Verdrengh M, Tarkowski A: Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. J Rheumatol. 2005, 32: 1513-1517.PubMed Verdrengh M, Tarkowski A: Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. J Rheumatol. 2005, 32: 1513-1517.PubMed
16.
go back to reference Kwasny-Krochin B, Bobek M, Kontny E, Gluszko P, Biedron R, Chain BM, Maslinski W, Marcinkiewicz J: Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1/J mice. Amino Acids. 2002, 23: 419-426.CrossRefPubMed Kwasny-Krochin B, Bobek M, Kontny E, Gluszko P, Biedron R, Chain BM, Maslinski W, Marcinkiewicz J: Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1/J mice. Amino Acids. 2002, 23: 419-426.CrossRefPubMed
17.
go back to reference Sermet-Gaudelus I, Le Cocguic Y, Ferroni A, Clairicia M, Barthe J, Delaunay JP, Brousse V, Lenoir G: Nebulized antibiotics in cystic fibrosis. Paediatr Drugs. 2002, 4: 455-467.CrossRefPubMed Sermet-Gaudelus I, Le Cocguic Y, Ferroni A, Clairicia M, Barthe J, Delaunay JP, Brousse V, Lenoir G: Nebulized antibiotics in cystic fibrosis. Paediatr Drugs. 2002, 4: 455-467.CrossRefPubMed
18.
go back to reference Ioannidou E, Siempos II, Falagas ME: Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother. 2007, 60: 1216-1226.CrossRefPubMed Ioannidou E, Siempos II, Falagas ME: Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother. 2007, 60: 1216-1226.CrossRefPubMed
19.
go back to reference Witko Sarsat V, Delacourt C, Rabier D, Bardet J, Nguyen AT, Descamps Latscha B: Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med. 1995, 152: 1910-1916.CrossRefPubMed Witko Sarsat V, Delacourt C, Rabier D, Bardet J, Nguyen AT, Descamps Latscha B: Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med. 1995, 152: 1910-1916.CrossRefPubMed
20.
go back to reference Cantin AM: Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J Clin Investig. 1994, 93: 606-614.CrossRefPubMedPubMedCentral Cantin AM: Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J Clin Investig. 1994, 93: 606-614.CrossRefPubMedPubMedCentral
21.
go back to reference Hofer E, Neher A, Gunkel AR, Nagl M: In vitro study on the influence of N-chlorotaurine on the ciliary beat frequency of nasal mucosa. Am J Rhinol. 2003, 17: 149-152.PubMed Hofer E, Neher A, Gunkel AR, Nagl M: In vitro study on the influence of N-chlorotaurine on the ciliary beat frequency of nasal mucosa. Am J Rhinol. 2003, 17: 149-152.PubMed
22.
go back to reference Geiger R, Pajk W, Neu N, Maier S, Kleinsasser A, Fratz S, Navarro-Psiha S, Fischer V, Treml B, Loeckinger A: Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration. Pediatr Res. 2006, 59: 147-150.CrossRefPubMed Geiger R, Pajk W, Neu N, Maier S, Kleinsasser A, Fratz S, Navarro-Psiha S, Fischer V, Treml B, Loeckinger A: Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration. Pediatr Res. 2006, 59: 147-150.CrossRefPubMed
23.
go back to reference Kleinsasser A, Lindner KH, Hoermann C, Schaefer A, Keller C, Loeckinger A: Isoflurane and sevoflurane anesthesia in pigs with a preexistent gas exchange defect. Anesthesiology. 2001, 95: 1422-1426.CrossRefPubMed Kleinsasser A, Lindner KH, Hoermann C, Schaefer A, Keller C, Loeckinger A: Isoflurane and sevoflurane anesthesia in pigs with a preexistent gas exchange defect. Anesthesiology. 2001, 95: 1422-1426.CrossRefPubMed
24.
go back to reference Kleinsasser A, Levin DL, Loeckinger A, Hopkins SR: A pig model of high altitude pulmonary edema. High Alt Med Biol. 2003, 4: 465-474.CrossRefPubMed Kleinsasser A, Levin DL, Loeckinger A, Hopkins SR: A pig model of high altitude pulmonary edema. High Alt Med Biol. 2003, 4: 465-474.CrossRefPubMed
25.
go back to reference Shekerdemian LS, Penny DJ, Ryhammer PK, Reader JA, Ravn HB: Endothelin-A receptor blockade and inhaled nitric oxide in a porcine model of meconium aspiration syndrome. Pediatr Res. 2004, 56: 353-358.CrossRefPubMed Shekerdemian LS, Penny DJ, Ryhammer PK, Reader JA, Ravn HB: Endothelin-A receptor blockade and inhaled nitric oxide in a porcine model of meconium aspiration syndrome. Pediatr Res. 2004, 56: 353-358.CrossRefPubMed
26.
go back to reference Brody S, Kibler HH: Resting energy metabolism and pulmonary ventilation in growing swine. Missouri Univ Agr Expt Sta Res Bull. 1944, 380: 2-20. Brody S, Kibler HH: Resting energy metabolism and pulmonary ventilation in growing swine. Missouri Univ Agr Expt Sta Res Bull. 1944, 380: 2-20.
27.
go back to reference Wagner PD, Naumann PF, Laravuso RB: Simultaneous measurement of eight foreign gases in blood by gas chromatography. J Appl Physiol. 1974, 36: 600-605.PubMed Wagner PD, Naumann PF, Laravuso RB: Simultaneous measurement of eight foreign gases in blood by gas chromatography. J Appl Physiol. 1974, 36: 600-605.PubMed
28.
go back to reference Wagner PD, Saltzman HA, West JB: Measurement of continuous distributions of ventilation-perfusion ratios: theory. J Appl Physiol. 1974, 36: 588-599.PubMed Wagner PD, Saltzman HA, West JB: Measurement of continuous distributions of ventilation-perfusion ratios: theory. J Appl Physiol. 1974, 36: 588-599.PubMed
29.
go back to reference Scholl-Bürgi S, Haberlandt E, Heinz-Erian P, Deisenhammer F, Albrecht U, Sigl SB, Rauchenzauner M, Ulmer H, Karall D: Amino acid cerebrospinal fluid/plasma ratios in children: influence of age, gender, and antiepileptic medication. Pediatrics. 2008, 121: e920-e926.CrossRefPubMed Scholl-Bürgi S, Haberlandt E, Heinz-Erian P, Deisenhammer F, Albrecht U, Sigl SB, Rauchenzauner M, Ulmer H, Karall D: Amino acid cerebrospinal fluid/plasma ratios in children: influence of age, gender, and antiepileptic medication. Pediatrics. 2008, 121: e920-e926.CrossRefPubMed
30.
go back to reference Amella C, Cappello F, Kahl P, Fritsch H, Lozanoff S, Sergi C: Spatial and temporal dynamics of innervation during the development of fetal human pancreas. Neuroscience. 2008, 154: 1477-1487.CrossRefPubMed Amella C, Cappello F, Kahl P, Fritsch H, Lozanoff S, Sergi C: Spatial and temporal dynamics of innervation during the development of fetal human pancreas. Neuroscience. 2008, 154: 1477-1487.CrossRefPubMed
31.
go back to reference Giese T, McGrath MS, Stumm S, Schempp H, Elstner E, Meuer SC: Differential effects on innate versus adaptive immune responses by WF10. Cell Immunol. 2004, 229: 149-158.CrossRefPubMed Giese T, McGrath MS, Stumm S, Schempp H, Elstner E, Meuer SC: Differential effects on innate versus adaptive immune responses by WF10. Cell Immunol. 2004, 229: 149-158.CrossRefPubMed
32.
go back to reference Putz G, Goerke J, Schürch S, Clements JA: Evaluation of pressure-driven captive bubble surfactometer. J Appl Physiol. 1994, 76: 1417-1424.PubMed Putz G, Goerke J, Schürch S, Clements JA: Evaluation of pressure-driven captive bubble surfactometer. J Appl Physiol. 1994, 76: 1417-1424.PubMed
33.
go back to reference Schoel WM, Schürch S, Goerke J: The captive bubble method for the evaluation of pulmonary surfactant: surface tension, area, and volume calculations. Biochim Biophys Acta. 1994, 1200: 281-290.CrossRefPubMed Schoel WM, Schürch S, Goerke J: The captive bubble method for the evaluation of pulmonary surfactant: surface tension, area, and volume calculations. Biochim Biophys Acta. 1994, 1200: 281-290.CrossRefPubMed
34.
go back to reference Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock RE: Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun. 2005, 73: 583-591.CrossRefPubMedPubMedCentral Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock RE: Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun. 2005, 73: 583-591.CrossRefPubMedPubMedCentral
35.
go back to reference Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G: A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976, 17: 62-70.CrossRefPubMed Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G: A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976, 17: 62-70.CrossRefPubMed
36.
go back to reference Nagl M, Miller B, Daxecker F, Ulmer H, Gottardi W: Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye – a phase I clinical study. J Ocular Pharmacol Ther. 1998, 14: 283-290.CrossRef Nagl M, Miller B, Daxecker F, Ulmer H, Gottardi W: Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye – a phase I clinical study. J Ocular Pharmacol Ther. 1998, 14: 283-290.CrossRef
37.
go back to reference Neher A, Fischer H, Appenroth E, Lass-Floerl C, Mayr A, Gschwendtner A, Ulmer H, Gotwald TF, Gstöttner M, Kozlov V, et al: Tolerability of N-Chlorotaurine in Chronic Rhinosinusitis Applied via Yamik Catheter. Auris Nasus Larynx. 2005, 32: 359-364.CrossRefPubMed Neher A, Fischer H, Appenroth E, Lass-Floerl C, Mayr A, Gschwendtner A, Ulmer H, Gotwald TF, Gstöttner M, Kozlov V, et al: Tolerability of N-Chlorotaurine in Chronic Rhinosinusitis Applied via Yamik Catheter. Auris Nasus Larynx. 2005, 32: 359-364.CrossRefPubMed
38.
go back to reference Rijnders BJ, Cornelissen JJ, Slobbe L, Becker MJ, Doorduijn JK, Hop WC, Ruijgrok EJ, Lowenberg B, Vulto A, Lugtenburg PJ, et al: Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin Infect Dis. 2008, 46: 1401-1408.CrossRefPubMed Rijnders BJ, Cornelissen JJ, Slobbe L, Becker MJ, Doorduijn JK, Hop WC, Ruijgrok EJ, Lowenberg B, Vulto A, Lugtenburg PJ, et al: Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin Infect Dis. 2008, 46: 1401-1408.CrossRefPubMed
39.
go back to reference Kontny E, Chorazy-Massalska M, Rudnicka W, Marcinkiewicz J, Maslinski W: Cytotoxicity of taurine metabolites depends on the cell type. Adv Exp Med Biol. 2006, 583: 157-171.CrossRefPubMed Kontny E, Chorazy-Massalska M, Rudnicka W, Marcinkiewicz J, Maslinski W: Cytotoxicity of taurine metabolites depends on the cell type. Adv Exp Med Biol. 2006, 583: 157-171.CrossRefPubMed
40.
go back to reference Huber J, Winter P, Gottardi W, Scholl-Bürgi S, Prokop W, Nagl M: Tolerability of N-chlorotaurine in the in the bovine mammary gland. J Dairy Res. 2008, 75: 248-256.CrossRefPubMed Huber J, Winter P, Gottardi W, Scholl-Bürgi S, Prokop W, Nagl M: Tolerability of N-chlorotaurine in the in the bovine mammary gland. J Dairy Res. 2008, 75: 248-256.CrossRefPubMed
41.
go back to reference Neher A, Gstöttner M, Nagl M, Scholtz A, Gunkel AR: N-Chlorotaurine – a New Safe Substance for Postoperative Ear Care. Auris Nasus Larynx. 2007, 34: 19-22.CrossRefPubMed Neher A, Gstöttner M, Nagl M, Scholtz A, Gunkel AR: N-Chlorotaurine – a New Safe Substance for Postoperative Ear Care. Auris Nasus Larynx. 2007, 34: 19-22.CrossRefPubMed
42.
go back to reference Romanowski EG, Yates KA, Teuchner B, Nagl M, Irschick EU, Gordon YJ: N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Invest Ophth Vis Sci. 2006, 47: 2021-2026.CrossRef Romanowski EG, Yates KA, Teuchner B, Nagl M, Irschick EU, Gordon YJ: N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Invest Ophth Vis Sci. 2006, 47: 2021-2026.CrossRef
43.
go back to reference Teuchner B, Schmid E, Ulmer H, Gottardi W, Nagl M: Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye – a phase 1 clinical study. Graefes Arch Clin Exp Ophthalmol. 2008, 246 (12): 1723-30.CrossRefPubMed Teuchner B, Schmid E, Ulmer H, Gottardi W, Nagl M: Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye – a phase 1 clinical study. Graefes Arch Clin Exp Ophthalmol. 2008, 246 (12): 1723-30.CrossRefPubMed
44.
go back to reference Blasco A, Joral A, Fuente R, Rodriguez M, Garcia A, Dominguez A: Bronchial asthma due to sensitization to chloramine T. J Investig Allergol Clin Immunol. 1992, 2: 167-170.PubMed Blasco A, Joral A, Fuente R, Rodriguez M, Garcia A, Dominguez A: Bronchial asthma due to sensitization to chloramine T. J Investig Allergol Clin Immunol. 1992, 2: 167-170.PubMed
45.
go back to reference Neher A, Nagl M, Schrott-Fischer A, Ichiki H, Gottardi W, Gunkel AR, Stephan K: N-chlorotaurine, a novel endogenous antimicrobial agent: tolerability tested in a mouse model. Arch Otolaryngol Head Neck Surg. 2001, 127: 530-533.CrossRefPubMed Neher A, Nagl M, Schrott-Fischer A, Ichiki H, Gottardi W, Gunkel AR, Stephan K: N-chlorotaurine, a novel endogenous antimicrobial agent: tolerability tested in a mouse model. Arch Otolaryngol Head Neck Surg. 2001, 127: 530-533.CrossRefPubMed
46.
go back to reference Gottardi W, Arnitz R, Nagl M: N-chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity. Int J Pharm. 2007, 335: 32-40.CrossRefPubMed Gottardi W, Arnitz R, Nagl M: N-chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity. Int J Pharm. 2007, 335: 32-40.CrossRefPubMed
47.
go back to reference Hedenstierna G, Rothen HU: Atelectasis formation during anesthesia: causes and measures to prevent it. J Clin Monit Comput. 2000, 16: 329-335.CrossRefPubMed Hedenstierna G, Rothen HU: Atelectasis formation during anesthesia: causes and measures to prevent it. J Clin Monit Comput. 2000, 16: 329-335.CrossRefPubMed
Metadata
Title
Tolerability of inhaled N-chlorotaurine in the pig model
Authors
Ralf Geiger
Benedikt Treml
Anna Pinna
Linn Barnickel
Harald Prossliner
Hannes Reinstadler
Michael Pilch
Maria Hauer
Christoph Walther
Hans-Jörg Steiner
Thomas Giese
Andreas Wemhöner
Sabine Scholl-Bürgi
Waldemar Gottardi
Roland Arnitz
Consolato Sergi
Markus Nagl
Alexander Löckinger
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2009
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-9-33

Other articles of this Issue 1/2009

BMC Pulmonary Medicine 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.